Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,564 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.
Niewoehner DE, Collins D, Erbland ML. Niewoehner DE, et al. Among authors: collins d. Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1201-5. doi: 10.1164/ajrccm.161.4.9907143. Am J Respir Crit Care Med. 2000. PMID: 10764312 Clinical Trial.
Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the Veterans Affairs HDL intervention trial (VA-HIT).
Georgopoulos A, Bloomfield H, Collins D, Brousseau ME, Ordovas JM, O'Connor JJ, Robins SJ, Schaefer EJ. Georgopoulos A, et al. Among authors: collins d. Atherosclerosis. 2007 Sep;194(1):169-74. doi: 10.1016/j.atherosclerosis.2006.07.022. Epub 2006 Aug 30. Atherosclerosis. 2007. PMID: 16945373 Clinical Trial.
Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).
Robins SJ, Rubins HB, Faas FH, Schaefer EJ, Elam MB, Anderson JW, Collins D; Veterans Affairs HDL Intervention Trial (VA-HIT). Robins SJ, et al. Among authors: collins d. Diabetes Care. 2003 May;26(5):1513-7. doi: 10.2337/diacare.26.5.1513. Diabetes Care. 2003. PMID: 12716814 Clinical Trial.
Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).
Rubins HB, Robins SJ, Collins D, Nelson DB, Elam MB, Schaefer EJ, Faas FH, Anderson JW. Rubins HB, et al. Among authors: collins d. Arch Intern Med. 2002 Dec 9-23;162(22):2597-604. doi: 10.1001/archinte.162.22.2597. Arch Intern Med. 2002. PMID: 12456232 Clinical Trial.
Subjects received either gemfibrozil (1200 mg/d) or matching placebo and were followed up for an average of 5.1 years. In this article, we report the composite end point (CHD death, stroke, or myocardial infarction). ...
Subjects received either gemfibrozil (1200 mg/d) or matching placebo and were followed up for an average of 5.1 years. In this articl …
Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial.
Nyman JA, Martinson MS, Nelson D, Nugent S, Collins D, Wittes J, Fye CL, Wilt TJ, Robins SJ, Bloomfield Rubins H; VA-HIT Study Group. Nyman JA, et al. Among authors: collins d. Arch Intern Med. 2002 Jan 28;162(2):177-82. doi: 10.1001/archinte.162.2.177. Arch Intern Med. 2002. PMID: 11802751 Clinical Trial.
Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group.
Rubins HB, Robins SJ, Collins D, Iranmanesh A, Wilt TJ, Mann D, Mayo-Smith M, Faas FH, Elam MB, Rutan GH, et al. Rubins HB, et al. Among authors: collins d. Am J Cardiol. 1995 Jun 15;75(17):1196-201. doi: 10.1016/s0002-9149(99)80761-9. Am J Cardiol. 1995. PMID: 7778538
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.
Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J. Rubins HB, et al. Among authors: collins d. N Engl J Med. 1999 Aug 5;341(6):410-8. doi: 10.1056/NEJM199908053410604. N Engl J Med. 1999. PMID: 10438259 Clinical Trial.
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.
Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, Anderson P, Morgan NA. Niewoehner DE, et al. Among authors: collins d. N Engl J Med. 1999 Jun 24;340(25):1941-7. doi: 10.1056/NEJM199906243402502. N Engl J Med. 1999. PMID: 10379017 Clinical Trial.
Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ, Rubins HB, Collins D, O'Connor TZ, Rutan GH, Robins SJ. Wilt TJ, et al. Among authors: collins d. Arch Intern Med. 1996 Jun 10;156(11):1181-8. Arch Intern Med. 1996. PMID: 8639012 Clinical Trial.
2,564 results
Jump to page
Feedback